Tocilizumab As a First Line Biologic Agent in Rheumatoid Arthritis Patients with Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs: Real Life Experience from the TReasure Registry.
Clinical and Experimental Rheumatology(2023)
Key words
tocilizumab,biological drugs,rheumatoid arthritis,drug retention,real life data
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined